General Information of Target

Target ID LDTP10652
Target Name NACHT, LRR and PYD domains-containing protein 3 (NLRP3)
Gene Name NLRP3
Gene ID 114548
Synonyms
C1orf7; CIAS1; NALP3; PYPAF1; NACHT, LRR and PYD domains-containing protein 3; EC 3.6.4.-; Angiotensin/vasopressin receptor AII/AVP-like; Caterpiller protein 1.1; CLR1.1; Cold-induced autoinflammatory syndrome 1 protein; Cryopyrin; PYRIN-containing APAF1-like protein 1
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MSAFSEAALEKKLSELSNSQQSVQTLSLWLIHHRKHSRPIVTVWERELRKAKPNRKLTFL
YLANDVIQNSKRKGPEFTKDFAPVIVEAFKHVSSETDESCKKHLGRVLSIWEERSVYEND
VLEQLKQALYGDKKPRKRTYEQIKVDENENCSSLGSPSEPPQTLDLVRALQDLENAASGD
AAVHQRIASLPVEVQEVSLLDKITDKESGERLSKMVEDACMLLADYNGRLAAEIDDRKQL
TRMLADFLRCQKEALAEKEHKLEEYKRKLARVSLVRKELRSRIQSLPDLSRLPNVTGSHM
HLPFAGDIYSED
Target Type
Clinical trial
Target Bioclass
Enzyme
Family
NLRP family
Subcellular location
Cytoplasm, cytosol
Function
Sensor component of the NLRP3 inflammasome, which mediates inflammasome activation in response to defects in membrane integrity, leading to secretion of inflammatory cytokines IL1B and IL18 and pyroptosis . In response to pathogens and other damage-associated signals that affect the integrity of membranes, initiates the formation of the inflammasome polymeric complex composed of NLRP3, CASP1 and PYCARD/ASC . Recruitment of pro-caspase-1 (proCASP1) to the NLRP3 inflammasome promotes caspase-1 (CASP1) activation, which subsequently cleaves and activates inflammatory cytokines IL1B and IL18 and gasdermin-D (GSDMD), promoting cytokine secretion and pyroptosis . Activation of NLRP3 inflammasome is also required for HMGB1 secretion; stimulating inflammatory responses. Under resting conditions, ADP-bound NLRP3 is autoinhibited. NLRP3 activation stimuli include extracellular ATP, nigericin, reactive oxygen species, crystals of monosodium urate or cholesterol, amyloid-beta fibers, environmental or industrial particles and nanoparticles, such as asbestos, silica, aluminum salts, cytosolic dsRNA, etc. Almost all stimuli trigger intracellular K(+) efflux. These stimuli lead to membrane perturbation and activation of NLRP3. Upon activation, NLRP3 is transported to microtubule organizing center (MTOC), where it is unlocked by NEK7, leading to its relocalization to dispersed trans-Golgi network (dTGN) vesicle membranes and formation of an active inflammasome complex. Associates with dTGN vesicle membranes by binding to phosphatidylinositol 4-phosphate (PtdIns4P). Shows ATPase activity.; Independently of inflammasome activation, regulates the differentiation of T helper 2 (Th2) cells and has a role in Th2 cell-dependent asthma and tumor growth. During Th2 differentiation, required for optimal IRF4 binding to IL4 promoter and for IRF4-dependent IL4 transcription. Binds to the consensus DNA sequence 5'-GRRGGNRGAG-3'. May also participate in the transcription of IL5, IL13, GATA3, CCR3, CCR4 and MAF.
TTD ID
T08499
Uniprot ID
Q96P20
DrugMap ID
TT4EN8X
HGNC ID
HGNC:16400
ChEMBL ID
CHEMBL1741208

Probe(s) Labeling This Target

ABPP Probe
Click To Hide/Show 4 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
DBIA
 Probe Info 
C730(1.52)  LDD3311  [1]
Acrolein
 Probe Info 
N.A.  LDD0222  [2]
IA-alkyne
 Probe Info 
N.A.  LDD0167  [3]
NAIA_5
 Probe Info 
N.A.  LDD2223  [4]

Competitor(s) Related to This Target

Competitor ID Name Cell line Binding Site(Ratio) Interaction ID Ref
 LDCM0296  AC35 PaTu 8988t C762(0.86); C770(0.86)  LDD1175  [5]
 LDCM0297  AC36 PaTu 8988t C762(0.99); C770(0.99)  LDD1176  [5]
 LDCM0298  AC37 PaTu 8988t C762(0.84); C770(0.84)  LDD1177  [5]
 LDCM0299  AC38 PaTu 8988t C762(1.07); C770(1.07)  LDD1178  [5]
 LDCM0300  AC39 PaTu 8988t C762(0.88); C770(0.88)  LDD1179  [5]
 LDCM0302  AC40 PaTu 8988t C762(0.95); C770(0.95)  LDD1181  [5]
 LDCM0303  AC41 PaTu 8988t C762(1.02); C770(1.02)  LDD1182  [5]
 LDCM0304  AC42 PaTu 8988t C762(1.05); C770(1.05)  LDD1183  [5]
 LDCM0305  AC43 PaTu 8988t C762(0.97); C770(0.97)  LDD1184  [5]
 LDCM0306  AC44 PaTu 8988t C762(0.93); C770(0.93)  LDD1185  [5]
 LDCM0307  AC45 PaTu 8988t C762(0.83); C770(0.83)  LDD1186  [5]
 LDCM0308  AC46 PaTu 8988t C762(0.68); C770(0.68)  LDD1187  [5]
 LDCM0309  AC47 PaTu 8988t C762(0.69); C770(0.69)  LDD1188  [5]
 LDCM0310  AC48 PaTu 8988t C762(0.53); C770(0.53)  LDD1189  [5]
 LDCM0311  AC49 PaTu 8988t C762(0.55); C770(0.55)  LDD1190  [5]
 LDCM0313  AC50 PaTu 8988t C762(0.60); C770(0.60)  LDD1192  [5]
 LDCM0314  AC51 PaTu 8988t C762(0.40); C770(0.40)  LDD1193  [5]
 LDCM0315  AC52 PaTu 8988t C762(0.63); C770(0.63)  LDD1194  [5]
 LDCM0316  AC53 PaTu 8988t C762(0.63); C770(0.63)  LDD1195  [5]
 LDCM0317  AC54 PaTu 8988t C762(0.55); C770(0.55)  LDD1196  [5]
 LDCM0318  AC55 PaTu 8988t C762(0.70); C770(0.70)  LDD1197  [5]
 LDCM0319  AC56 PaTu 8988t C762(0.61); C770(0.61)  LDD1198  [5]
 LDCM0320  AC57 PaTu 8988t C762(0.93); C770(0.93)  LDD1199  [5]
 LDCM0321  AC58 PaTu 8988t C762(0.88); C770(0.88)  LDD1200  [5]
 LDCM0322  AC59 PaTu 8988t C762(0.68); C770(0.68)  LDD1201  [5]
 LDCM0324  AC60 PaTu 8988t C762(0.91); C770(0.91)  LDD1203  [5]
 LDCM0325  AC61 PaTu 8988t C762(1.09); C770(1.09)  LDD1204  [5]
 LDCM0326  AC62 PaTu 8988t C762(1.03); C770(1.03)  LDD1205  [5]
 LDCM0327  AC63 PaTu 8988t C762(0.85); C770(0.85)  LDD1206  [5]
 LDCM0328  AC64 PaTu 8988t C762(1.10); C770(1.10)  LDD1207  [5]
 LDCM0329  AC65 PaTu 8988t C762(1.03); C770(1.03)  LDD1208  [5]
 LDCM0330  AC66 PaTu 8988t C762(1.12); C770(1.12)  LDD1209  [5]
 LDCM0331  AC67 PaTu 8988t C762(1.17); C770(1.17)  LDD1210  [5]
 LDCM0108  Chloroacetamide HeLa N.A.  LDD0222  [2]
 LDCM0387  CL117 PaTu 8988t C762(1.24); C770(1.24)  LDD1266  [5]
 LDCM0388  CL118 PaTu 8988t C762(1.03); C770(1.03)  LDD1267  [5]
 LDCM0389  CL119 PaTu 8988t C762(1.13); C770(1.13)  LDD1268  [5]
 LDCM0391  CL120 PaTu 8988t C762(1.07); C770(1.07)  LDD1270  [5]
 LDCM0392  CL121 PaTu 8988t C762(0.90); C770(0.90)  LDD1271  [5]
 LDCM0393  CL122 PaTu 8988t C762(0.59); C770(0.59)  LDD1272  [5]
 LDCM0394  CL123 PaTu 8988t C762(0.68); C770(0.68)  LDD1273  [5]
 LDCM0395  CL124 PaTu 8988t C762(0.70); C770(0.70)  LDD1274  [5]
 LDCM0396  CL125 PaTu 8988t C762(1.06); C770(1.06)  LDD1275  [5]
 LDCM0397  CL126 PaTu 8988t C762(0.96); C770(0.96)  LDD1276  [5]
 LDCM0398  CL127 PaTu 8988t C762(0.96); C770(0.96)  LDD1277  [5]
 LDCM0399  CL128 PaTu 8988t C762(1.00); C770(1.00)  LDD1278  [5]
 LDCM0453  CL61 PaTu 8988t C762(0.84); C770(0.84)  LDD1332  [5]
 LDCM0454  CL62 PaTu 8988t C762(0.77); C770(0.77)  LDD1333  [5]
 LDCM0455  CL63 PaTu 8988t C762(0.85); C770(0.85)  LDD1334  [5]
 LDCM0456  CL64 PaTu 8988t C762(0.82); C770(0.82)  LDD1335  [5]
 LDCM0457  CL65 PaTu 8988t C762(0.81); C770(0.81)  LDD1336  [5]
 LDCM0458  CL66 PaTu 8988t C762(0.79); C770(0.79)  LDD1337  [5]
 LDCM0459  CL67 PaTu 8988t C762(0.75); C770(0.75)  LDD1338  [5]
 LDCM0460  CL68 PaTu 8988t C762(0.95); C770(0.95)  LDD1339  [5]
 LDCM0461  CL69 PaTu 8988t C762(0.80); C770(0.80)  LDD1340  [5]
 LDCM0463  CL70 PaTu 8988t C762(0.84); C770(0.84)  LDD1342  [5]
 LDCM0464  CL71 PaTu 8988t C762(0.66); C770(0.66)  LDD1343  [5]
 LDCM0465  CL72 PaTu 8988t C762(0.94); C770(0.94)  LDD1344  [5]
 LDCM0466  CL73 PaTu 8988t C762(0.70); C770(0.70)  LDD1345  [5]
 LDCM0467  CL74 PaTu 8988t C762(0.74); C770(0.74)  LDD1346  [5]
 LDCM0468  Fragment33 PaTu 8988t C762(0.72); C770(0.72)  LDD1347  [5]
 LDCM0022  KB02 42-MG-BA C730(1.22)  LDD2244  [1]
 LDCM0023  KB03 42-MG-BA C730(1.55)  LDD2661  [1]
 LDCM0024  KB05 G361 C730(1.52)  LDD3311  [1]

The Interaction Atlas With This Target

The Protein(s) Related To This Target

Enzyme
Click To Hide/Show 4 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (DLST) 2-oxoacid dehydrogenase family P36957
NACHT, LRR and PYD domains-containing protein 3 (NLRP3) NLRP family Q96P20
Serine/threonine-protein kinase Nek7 (NEK7) NEK Ser/Thr protein kinase family Q8TDX7
Interferon-induced, double-stranded RNA-activated protein kinase (EIF2AK2) Ser/Thr protein kinase family P19525
Transporter and channel
Click To Hide/Show 1 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Calreticulin (CALR) Calreticulin family P27797
Other
Click To Hide/Show 2 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Apoptosis-associated speck-like protein containing a CARD (PYCARD) . Q9ULZ3
Mitochondrial antiviral-signaling protein (MAVS) . Q7Z434

The Drug(s) Related To This Target

Phase 2
Click To Hide/Show 1 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Dapansutrile . D0TH5H
Phase 1
Click To Hide/Show 1 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Bms-986299 Small molecular drug D75LNO
Investigative
Click To Hide/Show 1 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Mcc950 Small molecular drug D09FGL

References

1 DrugMap: A quantitative pan-cancer analysis of cysteine ligandability. Cell. 2024 May 9;187(10):2536-2556.e30. doi: 10.1016/j.cell.2024.03.027. Epub 2024 Apr 22.
Mass spectrometry data entry: PXD047840
2 ACR-Based Probe for the Quantitative Profiling of Histidine Reactivity in the Human Proteome. J Am Chem Soc. 2023 Mar 8;145(9):5252-5260. doi: 10.1021/jacs.2c12653. Epub 2023 Feb 27.
3 SP3-FAIMS Chemoproteomics for High-Coverage Profiling of the Human Cysteinome*. Chembiochem. 2021 May 14;22(10):1841-1851. doi: 10.1002/cbic.202000870. Epub 2021 Feb 18.
Mass spectrometry data entry: PXD023056 , PXD023059 , PXD023058 , PXD023057 , PXD023060
4 N-Acryloylindole-alkyne (NAIA) enables imaging and profiling new ligandable cysteines and oxidized thiols by chemoproteomics. Nat Commun. 2023 Jun 15;14(1):3564. doi: 10.1038/s41467-023-39268-w.
Mass spectrometry data entry: PXD041264
5 Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries. Nat Biotechnol. 2021 May;39(5):630-641. doi: 10.1038/s41587-020-00778-3. Epub 2021 Jan 4.